Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 5 (2008), Issue 5 (May)

1. Risk factors for complications after partial splenic embolization for liver cirrhosis.
   Br J Surg, 95(6): 744-50. [Abstract] [Full-text]
2. Diaphragmatic repair of two cases of hepatic hydrothorax using video-assisted thoracoscopic surgery.
   Gen Thorac Cardiovasc Surg, 56(5): 229-32. [Abstract] [Full-text]
3. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis.
   Am J Gastroenterol, 103(5): 1159-67. [Abstract] [Full-text]
4. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
   Am J Gastroenterol, 103(5): 1136-44. [Abstract] [Full-text]
5. Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study.
   Am J Gastroenterol, 103(5): 1152-8. [Abstract] [Full-text]
6. Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy.
   J Viral Hepat, 15(6): 427-33. [Abstract] [Full-text]
7. Induced hepatic fibrosis in rats: hepatic steatosis, macromolecule content, perfusion parameters, and their correlations--preliminary MR imaging in rats.
   Radiology, 247(3): 696-705. [Abstract] [Full-text]
8. Halofuginone upregulates the expression of heparanase in thioacetamide-induced liver fibrosis in rats.
   Lab Invest, 88(6): 627-33. [Abstract] [Full-text]

© 2004-2008 Liver Cirrhosis Research Today. All Rights Reserved.